TrialJournal of atherosclerosis and thrombosis2026
Cilostazol Contributes to Risk Reduction of Stroke Recurrence without Mediating a Reduction of Blood Pressure: Results from CSPS.com.
Kaori Miwa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.